| Primary |
| Diabetes Mellitus |
38.8% |
| Hypertension |
18.0% |
| Drug Use For Unknown Indication |
10.4% |
| Type 2 Diabetes Mellitus |
9.6% |
| Diabetes Mellitus Non-insulin-dependent |
3.8% |
| Prophylaxis |
3.2% |
| Dementia Alzheimer's Type |
3.0% |
| Hypothyroidism |
1.7% |
| Pain |
1.6% |
| Blood Cholesterol Increased |
1.2% |
| Myocardial Ischaemia |
1.2% |
| Atrial Fibrillation |
1.0% |
| Depression |
1.0% |
| Dementia |
0.9% |
| Inflammation |
0.9% |
| Vitamin B Complex Deficiency |
0.9% |
| Ankylosing Spondylitis |
0.7% |
| Arrhythmia |
0.7% |
| Hormone Replacement Therapy |
0.7% |
| Insomnia |
0.7% |
|
| Myocardial Ischaemia |
23.3% |
| Myocardial Infarction |
18.1% |
| Death |
9.1% |
| Cerebrovascular Accident |
8.1% |
| Weight Increased |
4.8% |
| Cardiac Failure Congestive |
4.6% |
| Injury |
4.4% |
| Oedema Peripheral |
4.2% |
| Cardiovascular Disorder |
3.9% |
| Chest Pain |
2.5% |
| Renal Failure |
2.5% |
| Vomiting |
2.1% |
| Oedema |
1.9% |
| Pneumonia |
1.7% |
| Transient Ischaemic Attack |
1.7% |
| Acute Myocardial Infarction |
1.5% |
| Cardiac Disorder |
1.5% |
| Dyspnoea |
1.3% |
| Necrosis |
1.3% |
| Constipation |
1.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.2% |
| Type 2 Diabetes Mellitus |
25.8% |
| Product Used For Unknown Indication |
20.4% |
| Diabetes Mellitus |
11.1% |
| Hypertension |
3.0% |
| Lipids Abnormal |
1.8% |
| Breast Cancer Metastatic |
1.1% |
| Completed Suicide |
1.1% |
| Hypertriglyceridaemia |
1.1% |
| Diabetes Mellitus Non-insulin-dependent |
0.9% |
| Insulin-requiring Type Ii Diabetes Mellitus |
0.5% |
| Stent Placement |
0.5% |
| Urinary Tract Infection |
0.5% |
| Amniotic Cavity Infection |
0.4% |
| Antibiotic Therapy |
0.4% |
| Hyperlipidaemia |
0.4% |
| Intentional Overdose |
0.4% |
| Suicide Attempt |
0.4% |
| Wound Infection Staphylococcal |
0.4% |
| Arthralgia |
0.2% |
|
| Myalgia |
16.0% |
| High Density Lipoprotein Decreased |
15.3% |
| Myocardial Ischaemia |
11.1% |
| Completed Suicide |
9.0% |
| Pulmonary Oedema |
6.3% |
| Death |
5.6% |
| Drug Interaction |
5.6% |
| Vomiting |
4.9% |
| Cardio-respiratory Arrest |
3.5% |
| Paradoxical Drug Reaction |
2.8% |
| Vitamin B12 Deficiency |
2.8% |
| Angioedema |
2.1% |
| Hypoglycaemia |
2.1% |
| Myocardial Infarction |
2.1% |
| Respiratory Arrest |
2.1% |
| Suicide Attempt |
2.1% |
| Vision Blurred |
2.1% |
| Weight Increased |
2.1% |
| Cardiac Arrest |
1.4% |
| Cellulitis |
1.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
34.9% |
| Diabetes Mellitus |
12.2% |
| Hypertension |
9.2% |
| Type 2 Diabetes Mellitus |
9.1% |
| Product Used For Unknown Indication |
5.9% |
| Diabetes Mellitus Non-insulin-dependent |
3.2% |
| Hiv Infection |
3.2% |
| Depression |
3.1% |
| Pain |
2.2% |
| Colorectal Cancer |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Hyperlipidaemia |
1.7% |
| Cervix Carcinoma |
1.6% |
| Schizophrenia |
1.4% |
| Cardiac Disorder |
1.3% |
| Hyperglycaemia |
1.3% |
| Blood Cholesterol |
1.0% |
| Neuropathy Peripheral |
1.0% |
|
| Vomiting |
16.0% |
| Weight Decreased |
9.4% |
| Sepsis |
8.5% |
| Rhabdomyolysis |
7.0% |
| Toxic Shock Syndrome |
6.1% |
| Renal Failure Acute |
5.6% |
| Psychotic Disorder |
5.2% |
| Treatment Noncompliance |
5.2% |
| Vision Blurred |
4.7% |
| Blood Glucose Increased |
3.8% |
| Syncope |
3.8% |
| High Density Lipoprotein Decreased |
3.3% |
| Small Intestinal Obstruction |
3.3% |
| Haemoglobin Decreased |
2.8% |
| Injection Site Pain |
2.8% |
| Tachycardia |
2.8% |
| Tremor |
2.8% |
| Blood Creatinine Increased |
2.3% |
| Epilepsy |
2.3% |
| Faecal Incontinence |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
62.4% |
| Lipids Abnormal |
9.2% |
| Drug Use For Unknown Indication |
5.5% |
| High Density Lipoprotein Increased |
5.5% |
| Type 2 Diabetes Mellitus |
5.5% |
| Diabetes Mellitus |
2.8% |
| Hyperuricaemia |
1.8% |
| Aortic Valve Replacement |
0.9% |
| Diabetes Mellitus Inadequate Control |
0.9% |
| Diabetes Mellitus Non-insulin-dependent |
0.9% |
| Hyperlipidaemia |
0.9% |
| Hypertension |
0.9% |
| Hypertriglyceridaemia |
0.9% |
| Immunosuppression |
0.9% |
| Proteinuria |
0.9% |
|
| High Density Lipoprotein Decreased |
56.3% |
| Drug Interaction |
34.4% |
| Myopathy |
3.1% |
| Transaminases Increased |
3.1% |
| Vitamin B12 Deficiency |
3.1% |
|
